Mylan NV (NASDAQ:MYL)’s share price gapped down prior to trading on Wednesday . The stock had previously closed at $32.44, but opened at $31.74. Mylan shares last traded at $31.25, with a volume of 5019329 shares changing hands.
Several equities research analysts have recently weighed in on the stock. Mizuho reaffirmed a “neutral” rating on shares of Mylan in a report on Thursday, January 31st. Zacks Investment Research lowered shares of Mylan from a “strong-buy” rating to a “hold” rating in a report on Wednesday, January 23rd. UBS Group lowered shares of Mylan from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $54.00 to $32.00 in a report on Wednesday, January 23rd. ValuEngine lowered shares of Mylan from a “sell” rating to a “strong sell” rating in a report on Wednesday, November 21st. Finally, Cantor Fitzgerald reaffirmed a “hold” rating and issued a $41.00 target price on shares of Mylan in a report on Tuesday, November 20th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and ten have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $42.86.
The company has a current ratio of 1.26, a quick ratio of 0.77 and a debt-to-equity ratio of 1.20. The firm has a market capitalization of $16.37 billion, a P/E ratio of 6.85, a PEG ratio of 1.05 and a beta of 1.63.
COPYRIGHT VIOLATION NOTICE: “Mylan (MYL) Shares Gap Down to $31.74” was originally reported by Markets Daily and is the sole property of of Markets Daily. If you are reading this report on another site, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this report can be viewed at https://www.themarketsdaily.com/2019/02/14/mylan-myl-shares-gap-down-to-31-74.html.
Mylan Company Profile (NASDAQ:MYL)
Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, brand name, and over-the-counter (OTC) products worldwide. The company operates through three segments: North America, Europe, and Rest of World. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.
Further Reading: Calculate Your Return on Investment (ROI)
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.